human trial of Neoagaro-oligosaccharides on decrease of body fat

16 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Neoagaro-oligosaccharides on decrease of body fat

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006640

Enrollment

100

Registered

2021-10-07

Start date

2021-10-01

Completion date

Unknown

Last updated

2023-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : • Neoagaro-oligosaccharides group: twice a day, 4 capsules at a time, oral intakes after breakfast/diner, for 16 weeks(3 g/day as Neoagaro-oligosaccharides) • Placebo group: twice

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 23 kg/m²=BMI(Body mass index)=34.9 kg/m², PBF(Percent body fat) is over 25% as male, over 30% as female. 2) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion criteria

Exclusion criteria: 1) Participants who have a change of weight over 10% within 3 months prior to the screening examination 2) Participants who have an obesity surgery within 1 year 3) Participants with a history of medicine abuse 4) Participants who have participated in other clinical trials within 3 months prior to the screening examination

Design outcomes

Primary

Measure	Time frame
Body fat mass	—

Secondary

Measure	Time frame
Fat free mass;Anthropometric index;Lipid metabolism index;Obesity hormone index	—

Countries

Korea, Republic of

Contacts

Public Contactjongcheon joo

Wonkwang University Oriental Medical Hospital, Jeonju

jcjoo2000@hanmail.net+82-63-270-1073

Outcome results